JPH02503314A - ヒトの異常脂肪血症治療剤 - Google Patents

ヒトの異常脂肪血症治療剤

Info

Publication number
JPH02503314A
JPH02503314A JP1500585A JP50058589A JPH02503314A JP H02503314 A JPH02503314 A JP H02503314A JP 1500585 A JP1500585 A JP 1500585A JP 50058589 A JP50058589 A JP 50058589A JP H02503314 A JPH02503314 A JP H02503314A
Authority
JP
Japan
Prior art keywords
phenylpropyl
ethyl
hydroxy
salicylamide
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1500585A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0532368B2 (cg-RX-API-DMAC7.html
Inventor
ダロー，ウィリアム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JPH02503314A publication Critical patent/JPH02503314A/ja
Publication of JPH0532368B2 publication Critical patent/JPH0532368B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1500585A 1987-11-30 1988-11-28 ヒトの異常脂肪血症治療剤 Granted JPH02503314A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US126,441 1987-11-30
US07/126,441 US4788183A (en) 1987-11-30 1987-11-30 Method for treatment of dyslipidemia in humans

Publications (2)

Publication Number Publication Date
JPH02503314A true JPH02503314A (ja) 1990-10-11
JPH0532368B2 JPH0532368B2 (cg-RX-API-DMAC7.html) 1993-05-14

Family

ID=22424849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1500585A Granted JPH02503314A (ja) 1987-11-30 1988-11-28 ヒトの異常脂肪血症治療剤

Country Status (10)

Country Link
US (1) US4788183A (cg-RX-API-DMAC7.html)
EP (2) EP0391958A1 (cg-RX-API-DMAC7.html)
JP (1) JPH02503314A (cg-RX-API-DMAC7.html)
KR (1) KR890701111A (cg-RX-API-DMAC7.html)
AU (1) AU2816889A (cg-RX-API-DMAC7.html)
DK (1) DK132090A (cg-RX-API-DMAC7.html)
HU (1) HUT53526A (cg-RX-API-DMAC7.html)
NZ (1) NZ227123A (cg-RX-API-DMAC7.html)
WO (1) WO1989005146A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA888993B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211947A (en) * 1988-12-16 1993-05-18 Schering Corporation Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
US6264960B1 (en) 1998-11-10 2001-07-24 Sander J. Robins Treatment of vascular events using lipid-modifying compositions
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
WO2006020999A2 (en) * 2004-08-19 2006-02-23 The United States Of America, As Represented By The Secretary Of Agriculture Pterostilbene as a new agonist for the peroxisome proliferator-activated receptor alpha isoform

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide

Also Published As

Publication number Publication date
WO1989005146A2 (en) 1989-06-15
NZ227123A (en) 1990-08-28
AU2816889A (en) 1989-07-05
DK132090D0 (da) 1990-05-29
HU890492D0 (en) 1990-09-28
EP0318889A3 (en) 1989-11-29
EP0318889A2 (en) 1989-06-07
HUT53526A (en) 1990-11-28
WO1989005146A3 (en) 1989-10-19
ZA888993B (en) 1989-07-26
DK132090A (da) 1990-05-29
US4788183A (en) 1988-11-29
KR890701111A (ko) 1989-12-19
JPH0532368B2 (cg-RX-API-DMAC7.html) 1993-05-14
EP0391958A1 (en) 1990-10-17

Similar Documents

Publication Publication Date Title
CA1322956C (en) Process for the production of dried earthworm powder and antihyperlipemic, antidiabetic, antihypertensive and antihypotensive preparations containing dried earthworm powder as active ingredient
JP6027722B2 (ja) 脳梗塞の予防及び治療用医薬品の製造におけるｌ−ブチルフタリドの使用
JPS62292732A (ja) 徐放性医薬組成物
JP2852608B2 (ja) 口腔乾燥症治療剤
EP0138216A2 (en) Sustained-release IFN preparation for parenteral administration
JP2000502994A (ja) 血管弛緩剤の組成物
CA2125822A1 (en) Therapeutic agent for alzheimer's disease
JP2951344B2 (ja) 化学療法における毒性特性の改良
JPH02503314A (ja) ヒトの異常脂肪血症治療剤
JP3982889B2 (ja) イブプロフェン含有医薬製剤
KR101697773B1 (ko) 독소필린을 포함하는 변형 방출 조성물
US4416898A (en) Therapeutic uses of methionine
US5082846A (en) Use of the R-(+)-isomer of 2-methoxy-3-octadecyloxy-propanol-(1)-phosphoric acid, monocholine ester in treating multiple sclerosis
US3932652A (en) Antidepressant compositions
KR20090024248A (ko) Ｃｘｃｒ2의 선택적 길항제 또는 ｃｘｃｒ1과 ｃｘｃｒ2 둘다의 선택적 길항제의 약제학적 제형 및 조성물, 및 염증성 질환을 치료하기 위한 이의 사용방법
WO1997029764A1 (fr) Activateurs cerebraux
JP3935539B2 (ja) フマル酸ケトチフェン含有医薬組成物
US3961073A (en) Antidepressant
JP2816500B2 (ja) 抗骨粗鬆剤
GB2064958A (en) Medicaments containing aspirin
JP3195916B2 (ja) Ａｉｄｓにおけるヘルパーｔ細胞数の減少抑制若しくは増加剤
JPH09208471A (ja) 動脈硬化抑制剤及びこれを含む食品又は医薬
JPS60202812A (ja) ブロモクリプチン組成物
US3126319A (en) Method for the potentiation of anti-
US3772440A (en) Method for the treatment of parkinsonism and depression